Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1321
Selected: 0
NCT IDTitle
NCT03132584Cyclophosphamide and Alemtuzumab In Lymphoma
NCT03692325Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
NCT00428233Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
NCT02656849BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
NCT00136539Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer
NCT06654466Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
NCT02400437Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia
NCT00148681Preoperative Herceptin and Navelbine for Breast Cancer
NCT00859222LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
NCT00142181Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia
NCT05469893Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
NCT04851522Dilute Bleach Compresses for Radiation Dermatitis
NCT02448537A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas
NCT03483012Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis
NCT00146601Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
NCT03858712EHR-embedded OCDT in Breast or GI Cancer
NCT01740219Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches
NCT00622401Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
NCT00137774Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors
NCT01970358A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma
NCT03587740ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
NCT04703426Sargramostim (GM-CSF) + PD-1
NCT01058239Bortezomib Plus Rituximab for EBV+ PTLD
NCT00545792Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers
NCT01415492Multiple Risk Behavior Intervention in Health Care Settings
NCT02269592Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
NCT00146536Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy
NCT02046811Reducing Skin Cancer Risk in Childhood Cancer Survivors
NCT04188535Serial MRI Scans During Radiation Therapy
NCT05463848Surgical Pembro +/- Olaparib w TMZ for rGBM
NCT00852852Computerized Assessment for Patients With Cancer
NCT03485547Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
NCT05057247Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC
NCT00973752Treatment of Older Adults With Acute Lymphoblastic Leukemia
NCT04893109ATEMPT 2.0: Adjuvant T-DM1 vs TH
NCT00165399Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment
NCT01185509Trastuzumab and Vinorelbine in Advanced Breast Cancer
NCT02207504Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer
NCT02164240Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST
NCT03894891Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer
NCT03993210The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids
NCT00165360Prolonged Daily Temozolomide for Low-Grade Glioma
NCT00123825Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer
NCT00953576Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
NCT02852655A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma
NCT00369226Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
NCT04634435Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
NCT00458653Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
NCT05509439Home Transfusion for HEME
NCT02041429Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca